Now I have all the information needed. Let me compose the final review.

## Summary

This paper identifies and formalizes the **dense-concentrated structure (DC-structure)** of molecular distributions, where chemically valid configurations correspond to narrow, densely packed probability peaks separated by low-density regions. The authors show that this structure makes diffusion-based molecular generation fragile: at intermediate timesteps, reverse updates can overshoot valid peaks and enter low-density regions where errors become irrecoverable. To address this, they propose **DIST** (Diffuse and Steer), a plug-in corrective sampling method that filters intermediate model-distribution batches via pilot reverse inferences, discarding batches inconsistent with the true marginal distribution. DIST is applied to three distinct backbone diffusion models (EDM, GeoLDM, RADM) without any weight modification and shows consistent improvements in atom stability, molecule stability, and validity on QM9 and GEOM-Drugs, while simultaneously reducing the average number of inference timesteps by roughly half.

## Strengths

1. **First formal characterization of the DC-structure of molecular distributions.** Definition 3.1 provides a clean, quantitative handle on the geometry that makes molecular diffusion fragile—narrow peaks (small σ\*) separated by low-density gaps. This formalization directly motivates the overshoot analysis (Eq. 6–7), which explains why small errors at intermediate timesteps cause irrecoverable drift in molecular generation, and moves the paper's contribution beyond heuristic observation.

2. **Model-agnostic plug-in architecture with consistent gains across diverse backbones.** DIST is applied to three fundamentally different backbones—an equivariant GNN (EDM), a latent-space equivariant model (GeoLDM), and a transformer-based non-equivariant model (RADM)—without altering any weights or hyperparameters. The improvements are monotonic across all metrics on both QM9 and GEOM-Drugs (Table 2). This breadth convincingly demonstrates that the DC-structure issue is architectural-independent and that DIST addresses a general failure mode.

3. **Simultaneous quality improvement and efficiency gain.** Table 3 shows DIST reduces the average number of reverse timesteps from 1000 to 413–637 while simultaneously improving generation quality. The ablation study (Table 4) further confirms a reliable quality–efficiency trade-off: even at the smallest pilot budget (30 pilots), DIST already outperforms the original EDM, and increasing pilot count yields monotonic improvement.

4. **Empirical demonstration that intermediate correction is needed beyond better architectures.** Table 1 shows that even starting from clean data and running only 100 reverse steps degrades molecule stability from 95.2% → 92.7%, with further degradation at more steps. This evidence, together with the consistent gains across backbones, supports the paper's central thesis that trajectory correction at intermediate timesteps is necessary and that architectural innovation alone is insufficient.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

1. **Computational cost accounting does not transparently include pilot overhead.** The efficiency analysis (Section 4.3) reports average timesteps as "total timestep consumption needed to generate 10,000 molecules" using the formula (T−t)/|B| + t, but it is not clearly stated whether the cost of running full reverse inferences on the pilot subsets is included. Since the pilot step performs a "full reverse inference on a pilot subset" (Section 3.2), this represents additional compute that should be accounted for in the efficiency claim. The paper references Appendix G.1 for detailed quantification (stripped by the parser), but the main text should at least clarify what is and is not included in the reported timestep counts.

2. **No direct comparison against simple post-hoc filtering.** DIST's core claim is that *intermediate* correction adds value beyond simply generating and then rejecting bad samples. A comparison against a baseline that generates 1000-step samples and then discards invalid molecules at the end (equivalent to EDM/RADM/GeoLDM standard sampling followed by validity filtering) would directly test this claim. Without such a comparison, it is unclear whether DIST's improvements come from steering or just from discarding bad trajectories at some stage.

3. **Theory–algorithm connection is somewhat loose.** While Corollary 3.1 (TV-contraction) and Proposition 3.1 (selective reverse error bound) provide a principled framework, the key design decisions of DIST—how the pilot score *sⱼ* is computed, how the threshold τ is set, how batches are constructed—are not guided by the theoretical analysis. Proposition 3.1 depends on the pilot scores correctly identifying low-density batches, but no analysis or empirical evidence links the pilot procedure to the theoretical conditions. The theory motivates *that* steering helps, but does not inform *how* the specific instantiation achieves it.

4. **GEOM-Drugs results lack variance estimates.** On QM9, three-run averages with standard deviations are reported, but GEOM-Drugs results are single values. The improvements on GEOM-Drugs are modest (e.g., GeoLDM atom stability 84.4 → 85.4, RADM 85.0 → 86.0), and without error bars or significance tests, it is difficult to assess whether these improvements are statistically reliable. (The paper's justification for omitting molecule stability on GEOM-Drugs—that it is "consistently close to 0%" for all methods following prior work convention—is reasonable and is not a weakness; the issue is specifically with the missing variance on reported metrics.)

5. **Zero standard deviations on atom stability are suspicious.** Table 2 reports atom stability for EDM+DIST on QM9 as 99.2±0.0. While likely an artifact of rounding to one decimal place, this appears implausible and should be reported with more precision or explained.

### Trivial
- The "first to highlight" claim in the contributions list is somewhat overstated given that prior work (Choi et al., 2025; Bohde et al., 2025) discusses related geometric constraints, though the *formalization* (Definition 3.1) is genuinely novel.
- No dedicated limitations section; the paper briefly mentions future work directions but does not discuss failure modes of DIST (e.g., when pilot evaluations are unreliable, threshold sensitivity, diversity reduction risk).

## Nice-to-Haves
- A comparison against a diversity-preserving baseline (e.g., DIST vs. standard sampling with post-hoc rejection) would strengthen the claim that intermediate steering is beneficial.
- Reporting standalone uniqueness on GEOM-Drugs (rather than only validity × uniqueness) would help verify that DIST does not collapse diversity.
- A sensitivity analysis for the key hyperparameters (threshold τ, intermediate timestep t, perturbation intensity) in the main paper body would be helpful; the paper defers this to Appendix H.

## Removed Points
The following points from the harsh critic were removed per the filtering rules:
- **"Method is insufficiently specified (pilot score not identified)"** — Removed because the paper explicitly states "please refer to Appendix F" for detailed settings. The appendix was stripped by the parser; the rule states to remove weaknesses about missing appendix content.
- **"Missing molecule stability on GEOM-Drugs is significant omission"** — Removed because the paper explicitly justifies this by citing prior work conventions (it is close to 0% for all methods). The paper does report atom stability and validity on GEOM-Drugs.
- **"Theory is decorative rather than instrumental"** — Downgraded from the critic's framing. The theory is genuinely connected: the DC-structure motivates the need for correction, and the TV-contraction and error bound provide guarantees. The looseness is real but minor (see Minor weakness 3).
- **"No limitations discussion"** — The paper concludes with future work directions that acknowledge limitations implicitly, though a dedicated limitations section would be nice. This is a minor presentation preference, not a weakness.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
- Clarify in the main text whether the reported timestep counts in Table 3 include pilot overhead, and if not, provide a revised table that does.
- Add a simple baseline: run standard sampling for each backbone, then post-hoc filter by validity. This directly tests whether DIST's intermediate correction is superior to end-of-pipe rejection.
- Report error bars or standard deviations for GEOM-Drugs results, or at minimum describe the number of runs and why variance is omitted.
- Add a brief limitations paragraph discussing potential failure modes: when the pilot evaluation is unreliable, risk of diversity loss from aggressive filtering, and threshold sensitivity.

## Score and Decision

**Calibration report:**

Round 1 bracket: [5.5, 7.0]

| Anchor | Avg Score | Round | Comparison |
|--------|-----------|-------|------------|
| kKXIYUi8ff (DynamicsDiffusion) | 3.00 | 1 (weak) | Much weaker — fundamental method issues, no theoretical grounding |
| rwmWd2rjP1 (MoreRed) | 4.75 | 1 (middle) | Weaker — limited evaluation, no model-agnostic demonstration |
| jZPqf2G9Sw (Protein Design) | 5.50 | 1 (middle) | Slightly weaker — evaluation largely qualitative, less empirical rigor |
| kzGuiRXZrQ (EQGAT-diff) | 5.75 | 1 (middle) | Comparable but different type — empirical design exploration; DIST has stronger theory |
| 5YLsnsjgeC (VFDiff) | 6.00 | 2 (narrow) | Comparable — both are corrective/guidance methods with clear improvements |
| 4dAgG8ma3B (Chemistry-Inspired) | 6.00 | 2 (narrow) | Comparable — similar level of contribution; DIST has better model-agnostic evidence |
| GK5ni7tIHp (TFG-Flow) | 6.25 | 2 (narrow) | Comparable — both are training-free guidance methods; DIST stronger on theory |
| CSj72Rr2PB (Bias Mitigation) | 6.50 | 2 (narrow) | Slightly stronger — cleaner story, more datasets; DIST has stronger theory but weaker presentation |
| pq1WUegkza (Score-Based Discrete) | 7.00 | 2 (narrow) | Stronger — pure theory paper with rigorous proofs; different genre |
| NSVtmmzeRB (GeoBFN) | 8.00 | 1 (strong) | Stronger — full end-to-end system with SOTA on all metrics |

The paper is strongest among the 4.75–6.0 range and comparable to the 6.00–6.25 anchors, while slightly weaker than the 6.50 anchor (Bias Mitigation) due to less complete efficiency accounting and missing variance on GEOM-Drugs.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>